|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM290826845 |
003 |
DE-627 |
005 |
20231225065546.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2019 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.201804971
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0969.xml
|
035 |
|
|
|a (DE-627)NLM290826845
|
035 |
|
|
|a (NLM)30450607
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Li, Li-Li
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Programmable Construction of Peptide-Based Materials in Living Subjects
|b From Modular Design and Morphological Control to Theranostics
|
264 |
|
1 |
|c 2019
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 31.03.2020
|
500 |
|
|
|a Date Revised 30.09.2020
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
520 |
|
|
|a Self-assembled nanomaterials show potential high efficiency as theranostics for high-performance bioimaging and disease treatment. However, the superstructures of pre-assembled nanomaterials may change in the complicated physiological conditions, resulting in compromised properties and/or biofunctions. Taking advantage of chemical self-assembly and biomedicine, a new strategy of "in vivo self-assembly" is proposed to in situ construct functional nanomaterials in living subjects to explore new biological effects. Herein, recent advances on peptide-based nanomaterials constructed by the in vivo self-assembly strategy are summarized. Modular peptide building blocks with various functions, such as targeting, self-assembly, tailoring, and biofunctional motifs, are employed for the construction of nanomaterials. Then, self-assembly of these building blocks in living systems to construct various morphologies of nanostructures and corresponding unique biological effects, such as assembly/aggregation-induced retention (AIR), are introduced, followed by their applications in high-performance drug delivery and bioimaging. Finally, an outlook and perspective toward future developments of in vivo self-assembled peptide-based nanomaterials for translational medicine are concluded
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Review
|
650 |
|
4 |
|a bioimaging
|
650 |
|
4 |
|a drug delivery
|
650 |
|
4 |
|a peptides
|
650 |
|
4 |
|a programmable
|
650 |
|
4 |
|a self-assembly
|
650 |
|
7 |
|a Peptides
|2 NLM
|
700 |
1 |
|
|a Qiao, Zeng-Ying
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Lei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Hao
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 31(2019), 45 vom: 01. Nov., Seite e1804971
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:31
|g year:2019
|g number:45
|g day:01
|g month:11
|g pages:e1804971
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201804971
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 31
|j 2019
|e 45
|b 01
|c 11
|h e1804971
|